All posts by imreal

A Framework for Reducing Risk and Timelines Through Careful Design and Planning for Downstream Services, Upcoming Webinar Hosted by Xtalks


Xtalks Life Science Webinars

Creating reliable animal models for long-term studies can often be problematic, not necessarily due to the complexity of the genetic modification(s) required, but with how that genetic modification will perform in the model.

Join experts from Envigo Lauren Klaskala, Project Manager – Custom Transgenic Models and Justin Zhao, PhD, Principal Scientist in a live webinar on Wednesday, July 8, 2020 at 11am EDT (4pm BST/UK).

Nuclease-based technologies such as CRISPR and ZFN have simplified the way we genetically engineer new models. However, while modifying the genome may be more straightforward, the challenge to create an optimal model for the desired application remains. Creating reliable animal models for long-term studies can often be problematic, not necessarily due to the complexity of the genetic modification(s) required, but with how that genetic modification will perform in the model. Suboptimal design strategies can compound these challenges by generating undesired genotypic or phenotypic results thus producing an ineffective model.

CRISPR-Cas9 or zinc-finger nuclease (ZFN)-based technologies can circumvent the challenges of complex genetic alterations due to their precision. When focusing on what the exact need or application will be for the model, optimal designs can be determined that then yield a reliable model for its specific application. Whether the modification to be produced is a humanization, replacement, conditional knockout, constitutive knockout, large deletion, point mutation, cDNA insertion, or reporter tagging, if careful consideration is given to the goal for the model usage and application, then optimal designs yield superior models.

When considering new model creation and development, scientists often focus on generating the model itself and overlook the downstream services required afterward, including initial model characterization, cryopreservation, breeding, and colony expansion. Envigo is the scientist alongside their customers – taking in all considerations for the model application and all the products and services needed to create, develop, and maintain the model.

For more information or to register for this event, visit CRISPR Generated Models: A Framework for Reducing Risk and Timelines Through Careful Design and Planning for Downstream Services.

ABOUT ENVIGO

Envigo provides the broadest range of research models and related services to the pharmaceutical and biotechnology industries, government, academia, and other life science organizations. As the largest organization that is solely dedicated to providing research models and related products and services, we are committed to helping researchers realize the full potential of their critical R&D projects as we fulfill our mission to work together to build a healthier and safer world. Read more at envigo.com.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Sydney Perelmutter

Tel: +1 (416) 977-6555 x 352

Email: sperelmutter@xtalks.com

Share article on social media or email:

The Miracle Project Announces Upcoming Virtual Musical Production, The Influencer


As they work together to virtually produce, edit, act, choreograph and compose original songs, they’re also expressing feelings, sharing imagination, emotional intelligence, and empathy for each other. Some experts might say that’s impossible – they’ve done the impossible.

The Miracle Project, a fully inclusive neurodiverse theater, film, social skills, and expressive arts program for individuals with autism and all abilities, is premiering the original musical film, The Influencer, via Zoom on June 25.

This original musical follows a close-knit Midwest family as they move to the big city and become negatively influenced by work, peer pressure, and social media. Created with, starring and filmed entirely during quarantine by teens and young adults on the autism spectrum and their peers, the musical deals with making choices between what others expect of you, who you want to be, and who you truly are.

Originally set to premiere as a staged production at the Wallis Annenberg Center for the Performing Arts in Beverly Hills, The Influencer will now be streamed twice, with the first showing on Thursday, June 25, at 5 p.m. (PST) and second on Sunday, June 28 at 4 p.m. (PST). Following each show, there will be a 15-minute live talkback Q&A discussion with the directors, editors, actors, and songwriters from The Miracle Project.

“It’s been a remarkable experience to watch our students produce an original musical from miles apart. Not only are they facing the challenges that quarantine brings everyone, but the students and young adults of The Miracle Project’s Company class have also debunked some of the common myths around autism,” said Elaine Hall, founder of The Miracle Project and director of The Influencer. As they work together to virtually produce, edit, act, choreograph and compose original songs, they’re also expressing feelings, sharing imagination, emotional intelligence, and empathy for each other. Some experts might say that’s impossible – they’ve done the impossible.”

Celebrating the diversity and inclusion of students with all abilities and those on the autism spectrum, The Miracle Project gives students the opportunity to express themselves through collaborating on creative ideas, writing, music, dancing, and acting.

RSVP’s required and can be made online at http://www.themiracleproject.org/theinfluencer. Once a guest has registered, they will receive a private zoom link for the musical.

The Miracle Project is based out of Los Angeles, Calif. For more information, please call (310) 829-7034 or visit https://themiracleproject.org/.

About The Miracle Project

The Miracle Project is a fully inclusive neurodiverse theater, film, social skills, and expressive arts program for individuals with autism and all abilities. Through shared creative experiences with peers, The Miracle Project encourages individuals with autism, other disabilities, and all abilities to develop social and job skills, enhance communication, increase self-awareness, and confidence, ease anxiety and find joy in the experience. For more information, visit https://themiracleproject.org/.

The Miracle Project | Los Angeles, CA 90036 | (310) 829-7034

Share article on social media or email:

Sun Mar Healthcare Celebrates COVID Infection Prevention Efforts with Churros


We are so humbled by the dedication of all the frontline staff during this unprecedented time. … We wanted to take a moment and thank them for their commitment to adhere to all the strict medical, hygiene and sanitizing guidelines.

Sun Mar Healthcare will be rewarding essential frontline employees working in nursing facilities through Southern California for exceptional successes in infection prevention as they continue to fight COVID-19. To celebrate, these men and women will be treated to all-you-can-eat churro parties at each facility, catered by San Diablo Artisan Churros.

During this pandemic, Sun Mar Heathcare’s top priority is to ensure all preventative measures are increased and strengthened to further limit the spread of COVID-19, ultimately protecting patients and the frontline workers who care for them. Sun Mar-affiliated employees remain vigilant as they continue to adhere to company-wide, CDC-directed health and cleanliness guidelines.

“We are so humbled by the dedication of all the frontline staff during this unprecedented time. They arrive every day with a smile and a loving heart to serve this senior population, most vulnerable to the virus. We wanted to take a moment and thank them for their commitment to adhere to all the strict medical, hygiene and sanitizing guidelines,” said Tammy Pirhekayati, Chief Clinical Officer for Sun Mar Healthcare.

Sun Mar Healthcare contracted with the award-winning, Utah-based San Diablo Artisan Churros to premiere their fresh-filled churros and launch their business in Southern California. Beginning Monday, June 22, each facility will be treated to the gourmet, fresh-filled churros.

For more information, contact Bryce Porter at BPorter@sunmarhealthcare.com, or call (949) 303-3082.

About Sun Mar Healthcare

Sun Mar Healthcare is a long-term care advisory and services organization providing operational support for 24 skilled nursing facilities and one assisted living facility. For over 35 years, Sun Mar has provided a broad array of services for health care facilities, including clinical system advisory and training, back-office accounting, legal and other services for owners and/or operators of long-term health care facilities.

Share article on social media or email:

ReFirm Labs Announces Spring 2020 Release of its IoT Firmware Security Platform to Address Growing Compliance Demands


News Image

IoT firmware is the next big attack vector. Yet IoT device manufacturers and users alike struggle to demonstrate compliance with these emerging standards and regulations due to the complicated, time intensive and expensive cybersecurity assessment process for these products.

ReFirm Labs, a provider of the industry’s first proactive IoT and firmware security solutions, today announced the Spring 2020 release of its flagship Centrifuge Platform®. Centrifuge vets, validates and continuously monitors the security of firmware – the software that runs IoT devices – to protect against emerging cyber threats. With this new release, Centrifuge continues to enhance the capabilities of its platform and introduces automated compliance reporting to address the rapidly increasing number of IoT industry standards and regulatory requirements.

Widely recognized as a pressing cybersecurity issue, firmware is a major unprotected attack surface that hackers use to get a foothold and move laterally into corporate or critical infrastructure networks. A host of emerging standards and regulations are being developed to address this threat by enforcing proper cyber hygiene by IoT device manufacturers. Recently both the US Cyberspace Solarium Commission and the NIST Cybersecurity for IoT Program released reports recommending stronger regulatory enforcement and clearer baseline standards and guidance for IoT device manufacturers and their supply chains in order to defend the country against cyberattacks. The Solarium report recommended Congress pass laws making device manufacturers liable for delivering products with known vulnerabilities.

“IoT firmware is the next big attack vector. Yet IoT device manufacturers and users alike struggle to demonstrate compliance with these emerging standards and regulations due to the complicated, time intensive and expensive cybersecurity assessment process for these products. Device manufacturers also need visibility into the security of third-party components from their supply chain. Automation of these assessments and validation early in the development process is the key to trust and managing risk throughout the IoT ecosystem,” said Derick Naef, CEO of ReFirm Labs.

He adds, “Just as organizations require a show of security and compliance due diligence for their enterprise applications, so should they be doing for their IoT devices.”

The Spring ’20 release of ReFirm Labs’ Centrifuge Platform introduces major new capabilities that expand the firmware security analysis platform to help automate and address the compliance and certification needs of embedded systems. Updates include:


  • Security Policy and Standards Compliance Validation: To help IoT device manufacturers integrate security policies into their quality checks and development process, these security policies can be defined and automatically checked against the Centrifuge analysis results. The new Centrifuge Policy Engine quickly determines if a product release is compliant, which saves time and money before starting an expensive and time consuming certification process. In addition, manufacturers can now enforce security compliance when receiving code from third parties before they accept new releases. And product security teams can quickly evaluate compliance before that equipment is placed on the network. Security policies can be customized and mapped to any one of the emerging security standards to verify standards compliance.
  • Firmware Comparison for Supply Chain Visibility: To address Cyber Supply Chain Risks, Centrifuge now supports firmware differencing. Product security teams can get a detailed view of what has changed between releases or within equipment in the field. This reduces the time required to conduct product security assessments. Now security analysts can focus on just those components that changed or identify changes they were not expecting. Automated firmware differencing provides a key capability to organizations standing up Cyber Supply Chain Risk Management programs as required by emerging industry regulations.

Other key improvements to Centrifuge’s core security analysis capabilities include:

  • Speed: Dramatically improved firmware extraction & analysis speed in some cases 10x faster
  • Expanded vulnerability coverage: 10 new analyzers for detecting known vulnerabilities in open source components, including Bluetooth, UPnP, and a variety of SSL security libraries
  • Expanded exploit coverage: 4 new detectors to identify exploits, including CABLEHAUNT and HiSilicon backdoors
  • PowerPC support: Binary analysis of firmware built for the PowerPC CPU architecture
  • Enhanced security: Support for two-factor authentication

Highly scalable, automated and cloud-based, the Centrifuge Platform is a simple and reliable way for monitoring security across an entire system of deployed IoT devices without the need for agents or access to the network itself. Centrifuge has been proven to increase productivity for security teams while reducing the number of breaches on internet-connected devices.

For more information about Centrifuge Platform®, go to https://www.refirmlabs.com/centrifuge-platform.

About ReFirm Labs

ReFirm Labs provides the industry’s first IoT and firmware security solutions that proactively vet, validate and continuously monitor IoT devices from hidden threats. Its flagship product, Centrifuge Platform®, detects and reports potential zero-day vulnerabilities, hidden crypto keys, backdoor passwords and known vulnerabilities in IoT devices without needing access to source code. ReFirm Labs’ technology has been proven to provide the insight and intelligence needed for users to proactively defend connected devices and maintain compliance and the integrity of supply chain security. Founded by a team of former NSA offensive cyber operators, ReFirm Labs is trusted by government agencies and Fortune 500 companies that operate in a wide variety of industries, including: telecommunications, cloud infrastructure and data centers, automotive, health care, utilities, and manufacturing. For more information, visit https://www.refirmlabs.com or follow on Twitter @ReFirmLabs.

Share article on social media or email:

Mark Oliver Joins Visionary Integration Professionals (VIP) as Infor Practice Director


News Image

“I am confident that Mark’s knowledge of Infor’s solutions and vast technical expertise will greatly benefit our clients in state and local government.” – Jonna Ward

Visionary Integration Professionals (VIP) announced today that Mark Oliver has joined its Public Sector team in the new role of Infor Practice Director.

Mark is a seasoned technology leader and joins VIP after more than 17 years in key leadership positions with Infor. He most recently served as Infor’s Director of Product Management, Public Sector, where he focused on solutions for Utility Billing, Asset Management, Community Development, Citizen Engagement and Regulation, such as permitting, licensing, and code enforcement.

“We are excited to have Mark join VIP as a member of the public sector group,” said Jonna Ward, Chairman & CEO of VIP. “I am confident that his deep knowledge of Infor’s solutions and vast technical expertise will greatly benefit our clients in state and local government.”

Mark will play a key role in expanding VIP’s capabilities and further developing the company’s go-to-market strategy to address important technology issues across agencies in California and other state and local markets.

About VIP

Visionary Integration Professionals (VIP) provides industry-leading management consulting, system integration, and technology deployment solutions. VIP helps its clients strengthen mission outcomes by combining deep industry specialization, agility to adapt as needed, and an unwavering commitment to client satisfaction. VIP brings expertise in how to deploy systems that align people, processes, and technology to accelerate strategic change and to deliver business results in partnership with its clients. Since 1996, VIP has worked with over 1,200 public sector and commercial clients. For more information, visit http://www.trustvip.com.

Share article on social media or email:

Tecate Group Announces Immediate Availability of Hybrid 3.8 Volt Capacitors


The TPLC™ series incorporates the key benefits of batteries while maintaining the traditional characteristics of ultracapacitors.

Tecate Group announces the introduction of its new family of hybrid lithium-ion capacitors (LICs), with a maximum rated voltage of 3.8V. The TPLC™ series incorporates the key benefits of batteries (increased voltage and energy density) while maintaining the traditional characteristics of ultracapacitors (rapid charge/discharge, environmental friendliness, longevity, and safety). The TPLC™ series features a mechanically robust cylindrical footprint with a compact profile, increased maximum rated voltage of 3.8V—one and a half times higher than the 2.7V of conventional ultracapacitors—and an energy density four to ten times greater than current comparably sized ultracapacitor-based technology.

These energy-dense cells can be used as stand-alone power sources or as load-leveling devices to increase the life of an existing primary energy source. The TPLC™ cells are ideally designed for use as a storage power or short-term backup power source for consumer devices, handheld scanners, data centers, military applications, metering, measuring equipment, portable machine tools, and other applications requiring more energy at higher voltage in a compact size. The TPLC™ cells are UL-recognized and RoHS- and REACH-compliant, with operating temperatures from -15ºC to +70ºC at 3.8V and extended operating temperatures of 15ºC to +85ºC at 3.5V while still providing a 500,000 rapid charge/discharge cycle life.

Tecate Group’s TPLC™ hybrid LIC series is the most extensive product portfolio in the market, with eighteen capacitance values ranging from 10F to 450F, multiple industry-standard case sizes, and custom cell sizes available on request.

For more information about Tecate Group’s innovative TPLC™ hybrid LIC series, visit http://www.tecategroup.com.

Digi-Key, https://www.digikey.com/, our global distribution partner, has the TPLC™ series in stock for immediate delivery.

Tecate Group is a world-recognized supplier of ultracapacitor products with exceptional power and energy density that are manufactured to the highest degree of quality and reliability. They are fully compliant with RoHS, REACH, and UL requirements. Our mission is to provide customer-driven power solutions through enhanced innovation in the development of standard products as well as customized cells and modules. Additional information can be found at http://www.tecategroup.com.

Share article on social media or email:

Hammes Company Healthcare celebrates groundbreaking of Moffitt Cancer Center hospital expansion


News Image

We are proud to be part of this exciting project, which supports Moffitt’s mission to contribute to the prevention and cure of cancer.

Hammes Company Healthcare, a leading provider of consulting and project delivery services to the healthcare industry, was honored to participate in the June 16th groundbreaking ceremony for the Moffitt Cancer Center hospital expansion in Tampa, Florida.

Hammes is serving as program manager for the development of a new, 20-acre property that will include a new 10-story, 498,000-square foot inpatient surgical hospital, central utility plant and three-story parking garage, and will be connected to Moffitt’s existing outpatient center on the same campus. The new hospital expansion will be developed in two phases, with the first phase including 128 inpatient beds with the capacity to expand to 400 beds.

“We are proud to be part of this exciting project, which supports Moffitt’s mission to contribute to the prevention and cure of cancer,” said Wade Milligan, Regional Vice President of Hammes Company Healthcare.

Construction for the new hospital will begin in July 2020 with occupancy anticipated for the summer of 2023.

Share article on social media or email:

The Grande is Recognized by Hernando Sun Reader’s Choice Awards for Assisted Living Facility / Professional Services and Retirement Facility / Independent Living


Hernando County Readers Choice Award

We are honored that Hernando Sun Readers recognize our outstanding staff and their effort towards improving health care quality and patient care for residents at The Grande.

Meridian Senior Living is thrilled to announce that its community The Grande was recognized with two Hernando Sun Silver Reader’s Choice awards on May 30th. The community was voted by Hernando Sun readers as a silver winner in the two categories: Assisted Living Facility / Professional Services and Retirement Facility/Independent Living. About 80,000 readers nominated service providers they consider the best in their particular category at the end of February through March and then cast their votes from April 1st through May 15th.

“We are honored that Hernando Sun Readers recognize our outstanding staff and their effort towards improving health care quality and patient care for residents at The Grande,” says Gloria Hughes, Meridian Senior Living Vice President of Operations. “This recognition reflects our staff’s commitment to deliver a high quality of care and to enrich the residents’ lives, because we believe; ‘Everyone deserves a great life.’”

Located at 725 Desoto Ave in Brooksville, FL, the Grande features independent living and assisted living residences with studio, shared suite, and private suite options. Spacious, bright community spaces underscore the community’s focus on active living: daily engaging and social activities, a dining experience with multiple dining options and venues, and the highest quality of care. For more information, visit thegrandeseniorliving.com, @TheGrande, or call (352) 414-4918.

About Meridian Senior Living:

Meridian Senior Living, a privately held company based in Bethesda, Maryland, owns and operates seniors housing communities across the country and provides operational consulting to 24 communities in China. With more than 70 communities in 21 states and more in development, Meridian is one of the largest seniors housing operators in the U.S. The company prides itself on providing the highest quality care, exceptional lifestyle programming and a distinctive dining experience for its residents. For more information on Meridian Senior Living, visit meridiansenior.com.

Share article on social media or email:

Verge Genomics Awarded as Technology Pioneer by World Economic Forum


It’s an honor to be acknowledged as a pioneer by the World Economic Forum”, said Verge Genomics’ Alice Zhang. “It is a confirmation that our platform is among the most innovative in the world and has a chance to improve the lives of many people with neurological diseases.”

Verge Genomics, the South San Francisco-based company that develops therapies for neurological diseases using machine learning, was selected among hundreds of candidates as one of the World Economic Forum’s “Technology Pioneers”. The company, co-founded in 2015 by CEO Alice Zhang, aims to shorten the time and cost it takes to discover drugs by using human genomics and machine learning.

The World Economic Forum’s Technology Pioneers are early to growth-stage companies from around the world that are involved in the design, development, and deployment of new technologies and innovations, and are poised to have a significant impact on business and society. The Technology Pioneers community is an integral part of the larger Global Innovators community of start-ups at the World Economic Forum.

“We’re excited to welcome Verge Genomics to our 20th cohort of Technology Pioneers,” says Susan Nesbitt, Head of the Global Innovators Community, World Economic Forum. “Verge Genomics and its fellow pioneers are developing cutting edge technologies all over the world. Beyond their innovations, these firms are contributing greatly to improving the state of the world.”

“It’s an honor to be acknowledged as a pioneer by the World Economic Forum”, said Verge Genomics’ Alice Zhang. “It is a confirmation that our platform is among the most innovative in the world and has a chance to improve the lives of many people with neurological diseases. We believe our technology can help decrease both the cost and time it takes to get therapies to the clinic, and we look forward to contributing to the Forum dialogues on this challenge.”

Following its selection as Technology Pioneer, CEO Alice Zhang of Verge Genomics will be invited to participate at World Economic Forum activities, events, and discussions throughout the year. Verge Genomics will also contribute to Forum initiatives over the next two years, working with policymakers and private sector leaders to help define the global agenda on key issues.

More Information about this year’s Technology Pioneers: Technology Pioneers have been selected based on the community’s selection criteria, which includes innovation, impact and leadership as well as the company’s relevance with the World Economic Forum’s Platforms. Throughout its 20-year run, many Technology Pioneers have continuously contributed to advancement in their industries while some have even gone on to become household names. Past recipients include Airbnb, Google, Kickstarter, Mozilla, Palantir Technologies, Spotify, TransferWise, Twitter and WikimediaWeb. Link: http://wef.ch/techpioneers20

About Verge Genomics: Verge Genomics is focused on developing therapeutics for neurological diseases using human genomics to accelerate drug discovery. Verge has created a proprietary all-in-human platform, generating one of the field’s largest and most comprehensive databases of ALS and Parkinson’s Disease patient genomic data. The Company is led by experienced computational biologists and drug developers who are successfully advancing therapeutic programs in ALS and Parkinson’s disease toward the clinic. For additional information, please visit http://www.vergegenomics.com.

About World Economic Forum: The World Economic Forum, committed to improving the state of the world, is the International Organization for Public-Private Cooperation. The Forum engages the foremost political, business and other leaders of society to shape global, regional and industry agendas. Link: http://www.weforum.org

About the Global Innovators: The Global Innovators Community is a group of the world’s most promising start-ups and scale-ups that are at the forefront of technological and business model innovation. The World Economic Forum provides the Global Innovators Community with a platform to engage with public- and private-sector leaders and to contribute new solutions to overcome current crises and build future resiliency.

Share article on social media or email:

uMETHOD Health Announces the Release of a Revolutionary Methodology to Help Prevent Alzheimer’s Disease and Cognitive Decline


News Image

uMETHOD is excited to announce the release of its breakthrough methodology — called ExtND METHOD — designed to finally provide a prevention solution to the over 70 million women and men in the USA at risk of Alzheimer’s disease and cognitive decline. The complexity of treating and preventing cognitive decline due to dozens of biological mechanisms and hundreds of interventions is now made straightforward through the application of uMETHOD’s proprietary methodology based on artificial intelligence. The ExtND METHOD enables doctors to have a straightforward way to practice and prevent brain decline, by providing personalized plans tailored to each individual. This solution has been developed and deployed at leading medical institutions across the US.

Today, there are no drugs that modify the course of Alzheimer’s disease. However, extensive research (such as the FINGER study and its worldwide follow-ons, and work at Weill Cornell) demonstrates value in early intervention and prevention for those at risk of Alzheimer’s disease. The biological progression of Alzheimer’s disease tends to start in the brain 10 to 20 years before the onset of symptoms. Thus, there is an opportunity to address its risk factors aggressively at younger ages – people in their 40s and 50s – long before symptoms can emerge. This is particularly urgent for those with a family history or a genetic risk of Alzheimer’s disease. Each person has unique genetics and their own unique set of health factors that drive cognitive decline. Personalized, multi-domain treatments are well-studied; when applied, they have been shown to alter the trajectory for developing Alzheimer’s disease.

uMETHOD uniquely focuses on this personalized approach to prevention. It uses artificial intelligence to interpret data from someone’s blood and urine tests, their demographics, their medical history, lifestyle, and more. The technology fits the person’s data against the wide scientific research on Alzheimer’s disease. It then produces individualized care plans that help doctors’ practice complex prevention methodologies – letting them work effectively with large numbers of patients within their community. uMETHOD’s methodologies are enhanced regularly to incorporate new research, so doctors apply the latest medical knowledge to the care of their patients.

“This is a landmark moment in the fight to tackle a debilitating disease that disproportionately affects women,” said Cindy Eckert, CEO of The Pink Ceiling. “Women comprise two-thirds of those diagnosed with Alzheimer’s today. It’s comforting to know that advanced technology is now being applied to stop decline or improve a remarkable 76% of patients. With uMETHOD’s technology as their backbone, major academic institutions will lead the way in bringing these new and effective treatment plans to the masses.”

“Several neurological diseases are now recognized as complex diseases with multiple underlying causes. Dementia and the spectrum of Alzheimer’s disease are the most prevalent.” said Christina Noble, Chief Growth Officer at Sonora Quest Laboratories in Arizona. “Personalized methodologies, such as those developed by uMETHOD Health, are the future for prevention and treatment of complex neurological disorders. The growing use of artificial intelligence has the potential to transform the care and outcomes of complex diseases.”

“The financial impact of Alzheimer’s disease to individuals, their families, and to the health system is large.” said Vik Chandra, CEO of uMETHOD Health. “Our society spends over $250B annually on the care of those with Alzheimer’s and other dementias. Availability of uMETHOD’s practical and effective prevention methodologies should help shrink the accelerating costs of caring for the elderly.”

About uMETHOD Health

Seventy-five percent of those over 65 have more than one chronic disease. This consumes 86% of healthcare spend in the United States. uMETHOD Health offers sophisticated precision-medicine methodologies that empower physicians to better manage the outcomes and costs of these complex chronic diseases through customized care. For more information visit http://www.umethod.com.

Share article on social media or email: